Bishal Gyawali1,2, Aaron S Kesselheim3. 1. Program on Regulation, Therapeutics and Law (PORTAL), Brigham and Women's Hospital, Harvard Medical School, Boston, USA. bg.bishalgyawali@gmail.com. 2. Department of Oncology, Department of Public Health Sciences and Division of Cancer Care and Epidemiology, Queen's University, Kingston, Canada. bg.bishalgyawali@gmail.com. 3. Program on Regulation, Therapeutics and Law (PORTAL), Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
Authors: Otto Metzger Filho; Daniel G Stover; Sarah Asad; Peter J Ansell; Mark Watson; Sibylle Loibl; Charles E Geyer; Junu Bae; Katharine Collier; Mathew Cherian; Joyce O'Shaughnessy; Michael Untch; Hope S Rugo; Jens B Huober; Mehra Golshan; William M Sikov; Gunter von Minckwitz; Priya Rastogi; David Maag; Norman Wolmark; Carsten Denkert; W Fraser Symmans Journal: JAMA Oncol Date: 2021-04-01 Impact factor: 31.777